Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Revenue | $1,023 | $141,706 | $128,330 | $1,078 |
| % Growth | -99.3% | 10.4% | 11,804.8% | – |
| Cost of Goods Sold | $425 | $62,735 | $415 | $450 |
| Gross Profit | $598 | $78,971 | $542 | $628 |
| % Margin | 58.5% | 55.7% | 0.4% | 58.3% |
| R&D Expenses | $71 | $60 | $73 | $95 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $474 | -$60 | $382 | $449 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$71 | $65,803 | $0 | $0 |
| Operating Expenses | $474 | $65,803 | $455 | $545 |
| Operating Income | $124 | $13,167 | $11,599 | $84 |
| % Margin | 12.1% | 9.3% | 9% | 7.8% |
| Other Income/Exp. Net | $64 | $6,019 | $4,514 | $32 |
| Pre-Tax Income | $188 | $19,186 | $16,113 | $116 |
| Tax Expense | $42 | $4,754 | $3,987 | $28 |
| Net Income | $143 | $13,969 | $88 | $9,658 |
| % Margin | 13.9% | 9.9% | 0.1% | 895.9% |
| EPS | 0.48 | 0.32 | 0.28 | 0.27 |
| % Growth | 50% | 14.3% | 3.7% | – |
| EPS Diluted | 0.48 | 0.32 | 0.28 | 0.27 |
| Weighted Avg Shares Out | 294 | 308 | 317 | 325 |
| Weighted Avg Shares Out Dil | 295 | 308 | 318 | 325 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18 | $2,564 | $7 | $153 |
| Interest Expense | $0 | $18 | $0 | $20 |
| Depreciation & Amortization | $42 | $5,172 | $37 | $4,321 |
| EBITDA | $230 | $24,376 | $157 | $17,297 |
| % Margin | 22.5% | 17.2% | 0.1% | 1,604.6% |